Insider buying · SEC Form 4

Insider Buying — Oct 21, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

7insider buys
$16.7Mbought in total
7companies
0by CEOs, CFOs and other chiefs
CRBGlargest: $12.1M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
CRBGCorebridge Financial, Inc.Nippon Life Insurance Co10% Owner$12.1M347,195$34.71AddedOct 20, 2026
Form 4 ↗
Purchased under a Rule 10b5-1 plan. Weighted avg price $34.71 (range $34.31–$35.07). Post-transaction position: ~129.85M shares. Strategic long-term investor in AIG life/annuity spinoff.
LEOBNY Mellon Strategic Municipals, Inc.Saba Capital Management, L.P. (Boaz R. Weinstein)10% Owner$1.92M338,104$5.67AddedOct 20, 2026
Form 4 ↗
Bought across 3 sessions (Oct 16–19) at ~$5.65 avg. Post-buy position: 6,428,634 shares. Part of Saba's ongoing closed-end fund discount arbitrage campaign. Current price $5.73 (+1.3%).
DSMBNY Mellon Strategic Municipal Bond Fund, Inc.Saba Capital Management, L.P.10% Owner$1.10M207,722$5.28AddedOct 20, 2026
Form 4 ↗
Three tranches: 48,135 @ $5.26, 90,507 @ $5.28, 69,080 @ $5.29 (Oct 16–19). Weighted avg ~$5.278. Current price $5.31 (+0.6%). Part of Saba's CEF discount campaign.
JOFJapan Smaller Capitalization Fund IncSaba Capital Management, L.P.10% Owner$552K46,222$11.94AddedOct 20, 2026
Form 4 ↗
Two tranches: 16,222 @ $11.94 (Oct 16) and 30,000 @ $11.94 (Oct 19). Weighted avg $11.94. Post-buy: 2,742,376 shares. Current price $11.83 (−0.9%). Part of Saba CEF campaign.
ECFEllsworth Growth & Income Fund LtdSaba Capital Management, L.P.10% Owner$386K33,426$11.56AddedOct 20, 2026
Form 4 ↗
Two tranches: 16,347 @ $11.65 (Oct 16) and 17,079 @ $11.47 (Oct 19). Weighted avg ~$11.558. Current price $11.46 (−0.9%). Part of Saba CEF campaign.
BOLDBoundless Bio, Inc.Kevin Tang / Tang Capital Management LLC10% Owner$350K149,474$2.34AddedOct 20, 2026
Form 4 ↗
Four tranches Oct 16–20 at ~$2.33–$2.37 avg. Weighted avg ~$2.339. Current price $2.43 (+3.9%). Tang Capital is a serial biotech deep-value activist. Boundless Bio is a small-cap oncology company.
GFNew Germany Fund IncSaba Capital Management, L.P.10% Owner$311K30,088$10.33AddedOct 20, 2026
Form 4 ↗
Two tranches: 15,042 @ $10.31 (Oct 16) and 15,046 @ $10.34 (Oct 19). Weighted avg ~$10.325. Current price $10.43 (+1.0%). Part of Saba CEF discount campaign.

AIThe day in insider buying

SEC Form 4 Insider Scan — October 21, 2026

Scanned the last 24 hours of EDGAR Form 4 filings. 7 qualifying buys (≥ $250K, transaction type P) totalling $16.7M.

Headline filings

  • CRBG — Nippon Life Insurance Co (10% Owner) bought 347,195 shares ≈ $12.05M at $34.71 avg; now $34.95 (+0.7% since buy). (filing)
  • LEO — Saba Capital Management, L.P. (10% Owner / Boaz Weinstein) bought 338,104 shares ≈ $1.92M at $5.654 avg; now $5.73 (+1.3% since buy). (filing)
  • DSM — Saba Capital Management, L.P. (10% Owner) bought 207,722 shares ≈ $1.10M at $5.278 avg; now $5.31 (+0.6% since buy). (filing)
  • JOF — Saba Capital Management, L.P. (10% Owner) bought 46,222 shares ≈ $551.9K at $11.94 avg; now $11.83 (−0.9% since buy). (filing)
  • ECF — Saba Capital Management, L.P. (10% Owner) bought 33,426 shares ≈ $386.3K at $11.558 avg; now $11.46 (−0.9% since buy). (filing)
  • BOLD — Kevin Tang / Tang Capital Management (10% Owner) bought 149,474 shares ≈ $349.6K at $2.339 avg; now $2.43 (+3.9% since buy). (filing)
  • GF — Saba Capital Management, L.P. (10% Owner) bought 30,088 shares ≈ $310.7K at $10.33 avg; now $10.43 (+1.0% since buy). (filing)

Notes

Dominant theme: Saba Capital's closed-end fund discount campaign. Boaz Weinstein's Saba Capital Management accounts for 5 of the 7 qualifying buys ($4.16M combined), continuing its systematic accumulation across BNY Mellon and other closed-end funds trading at discounts to NAV — LEO, DSM, JOF, ECF, and GF. This is a continuation of Saba's well-known activist CEF strategy.

Largest single buy: Nippon Life / Corebridge Financial (CRBG) — $12.05M. Nippon Life is a long-term strategic investor in Corebridge (the AIG life/annuity spinoff). This purchase was executed under a Rule 10b5-1 plan and lifts their position to ~129.85M shares (~26% stake). Life insurance / annuity sector continues to attract institutional conviction.

Biotech conviction buy: Boundless Bio (BOLD) — $349.6K. Kevin Tang's Tang Capital accumulated another 149,474 shares of this small-cap oncology company at ~$2.34, with the stock now trading at $2.43 (+3.9%). Tang is a serial biotech activist known for taking deep-value positions at distressed biotechs.

Market was pre-open at scan time (7:14 AM ET); all prices are from the prior session close or latest tick.

Most-bought stocks, last 30 days

  • LEN $405M · 2 buys, 2 insidersLennar Corporation
  • GME $104M · 8 buys, 3 insidersGameStop Corp.
  • CRBG $95.4M · 7 buys, 2 insidersCorebridge Financial, Inc.
  • GRAB $60.6M · 3 buys, 3 insidersGrab Holdings Ltd
  • GPI $56.8M · 3 buys, 2 insidersGroup 1 Automotive Inc.
  • BORR $51.3M · 8 buysBorr Drilling Ltd
  • ADRX $37.3M · 2 buys, 2 insidersADARx Pharmaceuticals, Inc.
  • BPRE $22.2M · 4 buysBluerock Private Real Estate Fund
  • QVCG $16.7M · 1 buyQVC Group, Inc.
  • AVR $16.6M · 4 buysAnteris Technologies Global Corp.
  • IAM $11.5M · 1 buyIambic Therapeutics, Inc.
  • COUR $11.4M · 1 buyCoursera, Inc.
  • PSUS $9.61M · 1 buyPershing Square USA, Ltd.
  • NYAX $9.22M · 2 buysNayax Ltd.
  • ENHA $6.99M · 1 buyEnhanced Group Inc
  • APLD $6.66M · 2 buys, 2 insidersApplied Digital Corp.
  • NFE $5.02M · 1 buyNew Fortress Energy Inc
  • GPUS $5.00M · 1 buyHyperscale Data, Inc.
  • GOLD $3.94M · 2 buys, 2 insidersGold.com, Inc.
  • ACCV $3.66M · 1 buyAccelevation Holdings Corp.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.